Direxion Daily Pharmaceutical & Medical Bull 3X Shares Rating $7.90 -0.03 (-0.38%) Closing price 04:10 PM EasternExtended Trading$7.90 0.00 (0.00%) As of 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily Pharmaceutical & Medical Bull 3X Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PILL Aggregate RatingModerate Buy 2.68Holdings in PILL have an aggregate rating of Moderate Buy based on 223 analyst ratings issued in the past year covering 21 companies (45.5% of the portfolio).PILL Aggregate Price Target$7.90High Prediction$7.90Average Prediction$7.90Low Prediction$7.90Holdings in PILL have an aggregate price target of $7.90 and a range of $7.90 to $7.90 covering 21 companies (45.5% of the portfolio).PILL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Pharmaceutical & Medical Bull 3X Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 PILL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.66%JNJJohnson & Johnson$175.50-0.7%4.8746 of 5 stars2.65$176.29 0.4%20Positive NewsOptions Volume2.63%RPRXRoyalty Pharma$35.62-1.2%4.9815 of 5 stars3.33$48.00 34.8%3Positive News2.44%TARSTarsus Pharmaceuticals$58.16+0.6%1.8276 of 5 stars3.00$66.67 14.6%7Positive News2.39%MRKMerck & Co., Inc.$83.24-1.0%4.997 of 5 stars2.35$107.44 29.1%20Positive News2.39%CORTCorcept Therapeutics$69.58-0.2%4.7604 of 5 stars3.00$134.50 93.3%5Positive News2.36%ELANElanco Animal Health$18.47-0.1%2.8586 of 5 stars2.78$17.33 -6.2%92.36%PFEPfizer$24.60-1.9%4.8486 of 5 stars2.39$28.12 14.3%18Trending News2.35%VTRSViatris$10.41-0.1%1.9555 of 5 stars1.80$10.40 -0.1%52.32%JAZZJazz Pharmaceuticals$126.13+1.4%4.7536 of 5 stars2.87$178.21 41.3%15Positive NewsAnalyst Forecast2.31%AXSMAxsome Therapeutics$121.75-0.1%4.7804 of 5 stars3.07$178.00 46.2%15News CoveragePositive NewsInsider Trade2.23%LLYEli Lilly and Company$732.25-0.3%4.9985 of 5 stars2.67$950.17 29.8%24Trending NewsAnalyst Upgrade2.16%BMYBristol Myers Squibb$46.89-1.6%4.7856 of 5 stars2.24$56.38 20.2%21Positive News2.13%PBHPrestige Consumer Healthcare$67.37+0.6%4.6876 of 5 stars2.50$93.33 38.5%6Positive News2.13%ZTSZoetis$154.79-0.4%4.9214 of 5 stars2.50$202.43 30.8%8Trending NewsAnalyst Revision2.09%OGNOrganon & Co.$9.18-0.3%4.7997 of 5 stars2.50$18.00 96.2%6Positive News2.08%PRGOPerrigo$23.78-0.5%4.9785 of 5 stars2.40$33.00 38.8%5Positive News1.92%HRMYHarmony Biosciences$37.97-0.2%4.6438 of 5 stars3.00$51.00 34.3%10Positive News1.74%SUPNSupernus Pharmaceuticals$45.37+0.7%2.1089 of 5 stars2.50$41.00 -9.6%4Insider Trade1.70%OCULOcular Therapeutix$12.52+1.6%4.0096 of 5 stars3.00$17.20 37.4%5Insider Trade1.61%ANIPANI Pharmaceuticals$92.53+0.7%3.2463 of 5 stars3.10$84.75 -8.4%10Insider Trade1.54%PCRXPacira BioSciences$26.85+2.8%3.337 of 5 stars2.71$30.83 14.8%7News CoveragePositive News This page (NYSEARCA:PILL) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Pharmaceutical & Medical Bull 3X Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily Pharmaceutical & Medical Bull 3X Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access